(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARRANTABIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ARRANTABIO

ST13

US500000088685994

Class

40, 42

Filing

88685994

Registration

6074538

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

06/10/2025

Trademark type

Combined

Nice classes

40, 42

Filing date

11/08/2019

Registration date

06/09/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/09/2020

Last transaction

06/10/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

10/28/2019

First use in commerce

10/28/2019

Drawing code

3

Owner type

16

Owner location

Watertown, MA

Examiner

SCHIMPF, TIMOTHY

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "ARRANTABIO". To the top right of wording are three v-shaped designs formed by curved oblongs.

Holders and representatives

Holders

Arranta Bio Holdings, LLC

Representatives

Jessica L. Rothstein Goodwin Procter LLP

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Manufacturing services for others in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; treatment of materialspharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals; contract manufacturing of pharmaceuticals and reagents; Manufacturing services for others in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products

Class 42

Research and development of pharmaceutical productsbiopharmaceutical productshealth care products and medical products; scientific and technological consulting services in the pharmaceutical industryresearch and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; pharmaceutical and biopharmaceutical drug development services; product development consultation; product research servicesproviding analytical testingbiosafety testingreporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays

Publications

History of USPTO decisions and trademark events.

21 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/09/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/19/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

11/19/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/19/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/19/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

06/09/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/24/2020

PUBO

PUBLISHED FOR OPPOSITION

03/24/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/04/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/14/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

02/12/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/12/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

02/12/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/12/2020

DOCK

ASSIGNED TO EXAMINER

02/12/2020

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

01/16/2020

ALIE

ASSIGNED TO LIE

01/14/2020

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

12/24/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/19/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/16/2019

NWAP

NEW APPLICATION ENTERED

11/12/2019

Continuous trademark protection

Get notified about every new filing that threatens ARRANTABIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.